Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator‐activated receptor‐γ coactivator‐1α and ‐1β in cultured myotubes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator‐activated receptor γ coactivator‐1 (PGC‐1) family is a key regulator of mitochondrial function, and reduced mRNA expression may contribute to muscle lipid accumulation in obesity and type 2 diabetes. To characterize the effects of PGC‐1 on lipid metabolism, we overexpressed PGC‐1α and PGC‐1β in C2C12 myotubes using adenoviral vectors. Both PGC‐1α and ‐1β increased palmitate oxidation [31% ( P <0.01) and 26% ( P <0.05) respectively] despite reductions in cellular uptake [by 6% ( P <0.05) and 21% ( P <0.001)]. Moreover, PGC‐1α and‐1β increased mRNA expression of genes regulating both lipid oxidation ( e.g. , CPT1b and ACADL/M ) and synthesis ( FAS, CS, ACC1/2 , and DGAT1 ). To determine the net effect, we assessed lipid composition in PGC‐1‐expressing cells. Total lipid content decreased by 42% in palmitate‐loaded serum‐starved cells overexpressing PGC‐1α ( P <0.05). In contrast, in serum‐replete cells, total lipid content was not significantly altered, but fatty acids C14:0, C16:0, C18:0, and C18:1 were increased 2‐ to 4‐fold for PGC‐1α/β ( P <0.05). Stable isotope‐based dynamic metabolic profiling in serum‐replete cells labeled with 13 C substrates revealed both increased de novo fatty acid synthesis from glucose and increased fatty acid synthesis by chain elongation with either PGC‐1α or ‐1β expression. These results indicate that PGC‐1 can promote both lipid oxidation and synthesis, with net balance determined by the nutrient/hormonal environment.—Espinoza, D. O., Boros, L. G., Crunkhorn, S., Gami, H., Patti, M.‐E. Dual Modulation of both lipid oxidation and synthesis by peroxisome proliferator‐activated receptor‐γ coactivator‐1α and ‐1β in cultured myotubes. FASEB J. 24, 1003–1014 (2010). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546 · cited 2×
“The net effect of PGC-1 activity in skeletal muscle is to increase mitochondrial biogenesis and oxidative phosphorylation (11), promote fiber type switching to more oxidative type I, IIA (6), or IIX fibers (7), and increase glucose uptake and glycogen storage (12), mediated in part via increased expression of the gluc…”
BackgroundDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“Both chronic insulin resistance and diabetes are accompanied by impaired oxidative capacity and “ectopic” lipid accumulation in muscle (33, 56, 57), including pathogenic ceramides and diacylglycerol lipid intermediates, among others (45).”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Self-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · cited 1×
“These effects may be mediated by coactivation of key transcription factors, including PPAR (1), hepatic nuclear factor 4 (2), nuclear respiratory factors (NRFs) (3), estrogen receptor-related receptor (ERR)- (official name ESRRA) (4), sterol regulatory element-binding protein 1 (5), myocyte enhancing factor 2 (6, 7),…”
BackgroundHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · cited 1×
“The PGC-1 family of genes regulates gene expression of both nuclear and mitochondrial-encoded genes (39).”
BackgroundVega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 3×
“Key Words: metabolomics fatty acid metabolism lipid metabolism The peroxisomal proliferator-activated receptor coactivator 1 (PGC-1) family of transcriptional coactivators, including PGC-1 , PGC-1 , and PGC-1-related coactivator (official gene names: PPARGC1A, PPARGC1B, and PPRC1), plays a central role in regulating t…”
BackgroundGoodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194 · cited 1×
“This perspective also suggests that increased lipid accumulation in the trained athlete (55) is actually a physiologically appropriate condition that may be mediated by repetitive exercise-induced increases in protein expression of PGC-1.”
BackgroundDefects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107
Cited by
Transcriptional integration of mitochondrial biogenesis
Scarpulla, R. C., Vega, R. B., & Kelly, D. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.006 · Cited by 798
The role of mitochondria in the pathogenesis of type 2 diabetes
Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551
Self-citationPGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation
Cheng, C.-F., Ku, H.-C., & Lin, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113447 · Cited by 437
Huang, D., Li, T., Li, X., Zhang, L., Sun, L., He, X., Zhong, X., Jia, D., Song, L., Semenza, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.028 · Cited by 352
Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation
Jing, E., O’Neill, B. T., Rardin, M. J., Kleinridders, A., Ilkeyeva, O. R., Ussar, S., Bain, J. R., Lee, K. Y., Verdin, E. M., Newgard, C. B., et al. (2013) · Diabetes · doi:10.2337/db12-1650 · Cited by 283
Mottillo, E. P., Balasubramanian, P., Lee, Y.-H., Weng, C., Kershaw, E. E., & Granneman, J. G. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m050005 · Cited by 281
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151
“Transcription factor PGC-1a decreases ROS formation (St-Pierre et al. 2006), equilibrates lipid oxidation and synthesis with direct effects on IMCL levels (Espinoza et al. 2010) and promotes mitochondrial biogenesis (Wende et al. 2007).”
BackgroundWright, L. E., Brandon, A. E., Hoy, A. J., Forsberg, G.-B., Lelliott, C. J., Reznick, J., Löfgren, L., Oscarsson, J., Strömstedt, M., Cooney, G. J., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2068-x · Cited by 57
Bosma, M. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.007 · Cited by 23
Metadata
- Authors
- Espinoza, D. O., Boros, L. G., Crunkhorn, S., Gami, H., & Patti, M.-E.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-11-11
- Volume
- 24
- Issue
- 4
- Pages
- 1003-1014
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1995877627
- Cited by
- 59
- References
- 32
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.